Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Joseph Disa

Plastic and Reconstructive Surgery New York, NY Medical Doctor

NPI 1710962709 CMS profile 169202

1275 York Ave, New York, NY 10021

Open in the dashboard

General payments

$20,803

200 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Joseph Disa of New York, NY is reported in the CMS Open Payments database as having received $20,803 across 200 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,329 21
2024 General $814 20
2023 General $800 15
2022 General $8,051 55
2021 General $4,789 50
2020 General $1,627 18
2019 General $3,392 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joseph Disa
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Joseph Disa were reported at $1,329. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Joseph Disa Plastic and Reconstructive Surgery median Middle half National median
2019 $3,392 $335 $121–$1,264 $163
2020 $1,627 $162 $57–$417 $114
2021 $4,789 $245 $89–$735 $132
2022 $8,051 $325 $120–$932 $149
2023 $800 $343 $129–$999 $160
2024 $814 $390 $141–$1,085 $164
2025 $1,329 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sientra, Inc. $11,323 100 payments
  2. Davol Inc. $4,149 14 payments
  3. AxoGen $1,286 13 payments
  4. Tepha Inc $943 12 payments
  5. Allergan Inc. $751 13 payments
  6. AbbVie, Inc. $668 28 payments
  7. Bard Peripheral Vascular, Inc. $335 5 payments
  8. Becton, Dickinson and Company $227 3 payments
  9. Vioptix Inc $222 1 payment
  10. RTI Surgical, Inc $219 3 payments
  11. Other $679 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $17,585 199 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,218 1 payment
Products named General payments · program years 2019–2025
  1. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $11,323 100 payments
  2. ALLODERM $1,008 33 payments
  3. GalaFLEX $943 12 payments
  4. Avance Nerve Graft $738 7 payments
  5. NATRELLE $345 6 payments
  6. ARISTA AH FlexiTip Surgery $336 4 payments
  7. ARISTA AH FLEXITIP BD Interventional Surgery $317 4 payments
  8. Phasix Mesh $316 2 payments
  9. CORTIVA ALLOGRAFT DERMIS $219 3 payments
  10. MENTOR MemoryGel Resterilizable Gel Sizer $196 3 payments
  11. Other $1,895 18 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 56 billing codes

Paid by Medicare

$127,344

Medicare's payments for the services billed

Medicare patients

201

Average age 71

Services billed

468

182 women, 19 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Cancer 75%
High blood pressure 57%
Arthritis 42%
Osteoporosis 33%
Depression 23%
Diabetes 18%
Ischemic heart disease 18%
COPD 9%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

200 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record